Skip to main content
Premium Trial:

Request an Annual Quote

Seeing Market Shift, Invitrogen to Exclusively Distribute Blue Heron's Synthetic Gene Products

NEW YORK (GenomeWeb News) — Invitrogen, saying it sees more researchers moving toward using synthetic genes over clones, today said it will exclusively distribute Blue Heron's synthetic gene products.
Through the agreement, Invitrogen said it will make an undisclosed investment in Blue Heron in exchange for exclusive worldwide distribution rights for the firm’s GeneMaker platform.
The agreement also allows the companies to co-develop new products and services, although Invitrogen did not offer more specifics about those plans.
According to Invitrogen, the synthetic gene platform made by Bothell, Wash-based Blue Heron can “synthesize any gene sequence,” making it “ideal for the synthetic biology market.”
Invitrogen said it believes the alliance will allow it to offer enhanced drug-discovery capabilities to its pharmaceutical and biotech clients.
Financial terms of the agreement were not disclosed.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.